Spencer to guide the institution on local, state and federal government issues Morehouse School of Medicine (MSM) is proud to announce that LaShannon Spencer, PhD, has joined MSM as Vice President of ...

Rev. Keith Norman; Dr. Audrey Townsel; Daniel Kiel; Toney Armstrong; Amber Sherman; Lucian Dervan; Zayid Saleem; Austin Wyatt ...

SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...

Photo: Getty Images An Elon Musk-run facility is releasing dangerous air pollution in South Memphis, putting the lives of families in predominately Black neighborhoods at risk, per the Southern ...

New Jersey's pharmaceutical industry supports 370,000 jobs and generates $130 billion a year, or 20% of the state's economy. It already faced pushback in recent years from Democrats such as former ...

If I had to choose a color, it would likely be Starlight. The yellow background was rather striking, and I think you’d be able to have fun with custom backgrounds and the sparkling gold tone.

Lexicon Pharmaceuticals LXRX has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...

Recursion Pharmaceuticals is harnesing the power ... You don't need a life-science background to see an opportunity to streamline this process with help from artificial intelligence (AI) and ...

Jazz Pharmaceuticals Background Information (This description is provided by the company.) Jazz Pharmaceuticals plc is a global biopharmaceutical company dedicated to developing and ...

In an effort to bolster the pharmaceutical sector, President Ferdinand Marcos Jr. signed into law the CREATE MORE Act, which will further enhance the investment landscape for all ventures into the ...

However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some analysts project that Rezdiffra could generate peak annual sales of close to $3.5 ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were soaring 15.2% higher as of 11:05 a.m. ET on Wednesday. The big gain came after the small biopharmaceutical company announced its fourth ...